ATE129288T1 - Impfstoffe, deren charakteristischer epitop in einem picornavirusprotein, insbesondere poliovirus, inkorporiert ist. - Google Patents

Impfstoffe, deren charakteristischer epitop in einem picornavirusprotein, insbesondere poliovirus, inkorporiert ist.

Info

Publication number
ATE129288T1
ATE129288T1 AT88402057T AT88402057T ATE129288T1 AT E129288 T1 ATE129288 T1 AT E129288T1 AT 88402057 T AT88402057 T AT 88402057T AT 88402057 T AT88402057 T AT 88402057T AT E129288 T1 ATE129288 T1 AT E129288T1
Authority
AT
Austria
Prior art keywords
poliovirus
vaccines
incorporated
characteristic epitope
picornavirus protein
Prior art date
Application number
AT88402057T
Other languages
English (en)
Inventor
Marc Girard
Czeslaw Wychowski
Annette Martin
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE129288T1 publication Critical patent/ATE129288T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88402057T 1987-08-07 1988-08-05 Impfstoffe, deren charakteristischer epitop in einem picornavirusprotein, insbesondere poliovirus, inkorporiert ist. ATE129288T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711337A FR2619012B1 (fr) 1987-08-07 1987-08-07 Vaccins dont l'epitope caracteristique est incorpore dans une proteine de picornavirus, notamment de poliovirus

Publications (1)

Publication Number Publication Date
ATE129288T1 true ATE129288T1 (de) 1995-11-15

Family

ID=9354047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88402057T ATE129288T1 (de) 1987-08-07 1988-08-05 Impfstoffe, deren charakteristischer epitop in einem picornavirusprotein, insbesondere poliovirus, inkorporiert ist.

Country Status (11)

Country Link
EP (1) EP0302801B1 (de)
JP (1) JPH01157380A (de)
AR (1) AR242057A1 (de)
AT (1) ATE129288T1 (de)
DE (1) DE3854591D1 (de)
DK (1) DK438288A (de)
FR (1) FR2619012B1 (de)
OA (1) OA08749A (de)
PT (1) PT88219B (de)
WO (1) WO1989001516A1 (de)
ZA (1) ZA885774B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
EP0436634A1 (de) * 1988-10-03 1991-07-17 Repligen Corporation Hiv-proteine und peptide und deren verwendung zur diagnose, prophylaxe und therapie von aids
WO1990015145A2 (en) * 1989-05-31 1990-12-13 Medical Research Council Poliovirus chimaeras
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
EP1288304A3 (de) * 1989-06-01 2006-04-05 Applied Biotechnology, Inc. Selbstzusammengesetzte, Defekte, sich Nichtselbstvermehrende
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
DE69131908T3 (de) * 1991-02-19 2008-04-03 Oxford Biomedica (Uk) Ltd. Viruspartikel mit veraendertem wirtspektrum
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
GB9125896D0 (en) * 1991-12-05 1992-02-05 Almond Jeffrey W Bicistronic viruses
JPH08511165A (ja) * 1993-06-03 1996-11-26 インスティチュート・パスツール 外来性ポリペプチドの発現のためのベクターとしてのメンゴウイルス
US6071742A (en) * 1997-03-05 2000-06-06 Board Of Regents Of The University Of Nebraska Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
WO2000014263A2 (en) * 1998-09-03 2000-03-16 Board Of Regents, The University Of Texas System Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
AU2005262317B2 (en) 2004-07-13 2009-07-16 Gen-Probe Incorporated Compositions and methods for detection of hepatitis A virus nucleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins

Also Published As

Publication number Publication date
DE3854591D1 (de) 1995-11-23
EP0302801B1 (de) 1995-10-18
PT88219B (pt) 1995-09-12
WO1989001516A1 (fr) 1989-02-23
FR2619012B1 (fr) 1989-12-22
AR242057A1 (es) 1993-02-26
DK438288A (da) 1989-04-10
DK438288D0 (da) 1988-08-05
PT88219A (pt) 1989-06-30
EP0302801A1 (de) 1989-02-08
JPH01157380A (ja) 1989-06-20
ZA885774B (en) 1989-04-26
OA08749A (fr) 1989-03-31
FR2619012A1 (fr) 1989-02-10

Similar Documents

Publication Publication Date Title
DE3854591D1 (de) Impfstoffe, deren charakteristischer Epitop in einem Picornavirusprotein, insbesondere Poliovirus, inkorporiert ist.
DE3785994D1 (de) Antikoerper gegen interleukin-1.
FI891896L (fi) Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa
DE3879452D1 (de) Chimaere antikoerper.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
DE59000601D1 (de) Treibstangenschloss.
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
DE69004249D1 (de) Ventil.
DE69007522D1 (de) Brennstabbündelfussstück mit Teilchenfangvorrichtung und Brennstabbündel mit einem solchen Fussstück.
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO904342D0 (no) Fiskevaksine omfattende en virulent, inntrengende bakterie
DE58900305D1 (de) Regelverfahren und -vorrichtung, insbesondere lambdaregelung.
NO166420C (no) Ventil.
EP0292293A3 (en) Newcastle disease virus vaccine and method for the applicaton thereof
DE69021761D1 (de) Impfstoff gegen Tinea.
DE68905101D1 (de) Ventil.
FI905532A7 (fi) Menetelmä valmistaa puhtaita, epäsymmetrisesti disubstituoituja karbamideja
IT8821556A0 (it) Peptidi immunostimolanti.
IL85980A0 (en) Disease control in avian species by embryonal vaccination with a non-replicating immunogen
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
DE69020848D1 (de) Impfstoff gegen IBV.
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
DE68918189D1 (de) Neisseria-Vakzine.
FR2676415B1 (fr) Servomoteur pneumatique.
IL88622A0 (en) Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same